What Is a Millionaire-Maker Stock?
From time to time, investors will run across the term…
Sell
35
ICLR Quote, Financials, Valuation and Earnings
Last price:
$133.89
Seasonality move
:
15.96%
Day range:
$137.85 - $141.96
52-week range:
$133.28 - $347.72
Dividend yield:
0%
P/E ratio:
15.09x
P/S ratio:
1.39x
P/B ratio:
1.16x
Volume:
3M
Avg. volume:
1.9M
1-year change:
-55.58%
Market cap:
$11B
Revenue:
$8.3B
EPS (TTM):
$9.18
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ICLR
Icon PLC
|
$2B | $3.09 | -6.81% | 83.44% | $183.75 |
|
APDN
Applied DNA Sciences
|
$1.2M | -$3.00 | 27.47% | -98.87% | -- |
|
FONR
Fonar
|
-- | -- | -- | -- | -- |
|
PRPH
ProPhase Labs
|
$2.5M | -$0.18 | -32.58% | -48.57% | $13.80 |
|
VCYT
Veracyte
|
$111M | $0.20 | 6.64% | 338.71% | $40.50 |
|
XWEL
XWELL
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ICLR
Icon PLC
|
$138.48 | $183.75 | $11B | 15.09x | $0.00 | 0% | 1.39x |
|
APDN
Applied DNA Sciences
|
$0.85 | -- | $933.7K | -- | $0.00 | 0% | 0.05x |
|
FONR
Fonar
|
$12.55 | -- | $79.5M | 10.91x | $0.00 | 0% | 0.79x |
|
PRPH
ProPhase Labs
|
$0.30 | $13.80 | $12.7M | -- | $0.00 | 0% | 0.92x |
|
VCYT
Veracyte
|
$31.21 | $40.50 | $2.4B | 76.12x | $0.00 | 0% | 5.33x |
|
XWEL
XWELL
|
$0.86 | -- | $4.5M | -- | $0.00 | 0% | 0.12x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ICLR
Icon PLC
|
26.47% | 0.899 | 24.6% | 1.21x |
|
APDN
Applied DNA Sciences
|
-- | 5.301 | -- | 4.28x |
|
FONR
Fonar
|
0.03% | 1.233 | 0.07% | 10.85x |
|
PRPH
ProPhase Labs
|
31.06% | -4.436 | 37.21% | 1.12x |
|
VCYT
Veracyte
|
-- | 3.551 | -- | 4.54x |
|
XWEL
XWELL
|
-- | -0.848 | -- | 1.72x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ICLR
Icon PLC
|
$558.7M | $264.3M | 5.83% | 7.93% | 11.06% | $239.3M |
|
APDN
Applied DNA Sciences
|
$684.1K | -$3M | -113.07% | -113.07% | -247.7% | -$3.4M |
|
FONR
Fonar
|
$9.7M | $2.4M | 4.95% | 4.95% | 11.92% | $1.5M |
|
PRPH
ProPhase Labs
|
-$165K | -$7.9M | -47.22% | -59.59% | -252.29% | -$4.2M |
|
VCYT
Veracyte
|
$79.5M | $1.2M | 2.85% | 2.85% | 1.02% | $3.5M |
|
XWEL
XWELL
|
$2.1M | -$4.6M | -71.82% | -71.82% | -54.82% | -$3.8M |
Icon PLC vs. Competitors
-
Which has Higher Returns ICLR or APDN?
Applied DNA Sciences has a net margin of 7.7% compared to Icon PLC's net margin of -220.57%. Icon PLC's return on equity of 7.93% beat Applied DNA Sciences's return on equity of -113.07%.
Company Gross Margin Earnings Per Share Invested Capital ICLRIcon PLC27.91% $1.90 $12.9B APDNApplied DNA Sciences57.17% -$28.00 $12.5M -
What do Analysts Say About ICLR or APDN?
Icon PLC has a consensus price target of $183.75, signalling upside risk potential of 32.69%. On the other hand Applied DNA Sciences has an analysts' consensus of -- which suggests that it could grow by 177225.93%. Given that Applied DNA Sciences has higher upside potential than Icon PLC, analysts believe Applied DNA Sciences is more attractive than Icon PLC.
Company Buy Ratings Hold Ratings Sell Ratings ICLRIcon PLC11 7 0 APDNApplied DNA Sciences0 1 0 -
Is ICLR or APDN More Risky?
Icon PLC has a beta of 1.233, which suggesting that the stock is 23.253% more volatile than S&P 500. In comparison Applied DNA Sciences has a beta of 0.405, suggesting its less volatile than the S&P 500 by 59.491%.
-
Which is a Better Dividend Stock ICLR or APDN?
Icon PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Applied DNA Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Icon PLC pays -- of its earnings as a dividend. Applied DNA Sciences pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or APDN?
Icon PLC quarterly revenues are $2B, which are larger than Applied DNA Sciences quarterly revenues of $1.2M. Icon PLC's net income of $154.2M is higher than Applied DNA Sciences's net income of -$2.6M. Notably, Icon PLC's price-to-earnings ratio is 15.09x while Applied DNA Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Icon PLC is 1.39x versus 0.05x for Applied DNA Sciences. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRIcon PLC1.39x 15.09x $2B $154.2M APDNApplied DNA Sciences0.05x -- $1.2M -$2.6M
-
Which has Higher Returns ICLR or FONR?
Fonar has a net margin of 7.7% compared to Icon PLC's net margin of 7.87%. Icon PLC's return on equity of 7.93% beat Fonar's return on equity of 4.95%.
Company Gross Margin Earnings Per Share Invested Capital ICLRIcon PLC27.91% $1.90 $12.9B FONRFonar39.03% $0.29 $159M -
What do Analysts Say About ICLR or FONR?
Icon PLC has a consensus price target of $183.75, signalling upside risk potential of 32.69%. On the other hand Fonar has an analysts' consensus of -- which suggests that it could fall by --. Given that Icon PLC has higher upside potential than Fonar, analysts believe Icon PLC is more attractive than Fonar.
Company Buy Ratings Hold Ratings Sell Ratings ICLRIcon PLC11 7 0 FONRFonar0 0 0 -
Is ICLR or FONR More Risky?
Icon PLC has a beta of 1.233, which suggesting that the stock is 23.253% more volatile than S&P 500. In comparison Fonar has a beta of 1.003, suggesting its more volatile than the S&P 500 by 0.30600000000001%.
-
Which is a Better Dividend Stock ICLR or FONR?
Icon PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Fonar offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Icon PLC pays -- of its earnings as a dividend. Fonar pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or FONR?
Icon PLC quarterly revenues are $2B, which are larger than Fonar quarterly revenues of $25M. Icon PLC's net income of $154.2M is higher than Fonar's net income of $2M. Notably, Icon PLC's price-to-earnings ratio is 15.09x while Fonar's PE ratio is 10.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Icon PLC is 1.39x versus 0.79x for Fonar. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRIcon PLC1.39x 15.09x $2B $154.2M FONRFonar0.79x 10.91x $25M $2M
-
Which has Higher Returns ICLR or PRPH?
ProPhase Labs has a net margin of 7.7% compared to Icon PLC's net margin of -209.38%. Icon PLC's return on equity of 7.93% beat ProPhase Labs's return on equity of -59.59%.
Company Gross Margin Earnings Per Share Invested Capital ICLRIcon PLC27.91% $1.90 $12.9B PRPHProPhase Labs-5.25% -$0.35 $55.3M -
What do Analysts Say About ICLR or PRPH?
Icon PLC has a consensus price target of $183.75, signalling upside risk potential of 32.69%. On the other hand ProPhase Labs has an analysts' consensus of $13.80 which suggests that it could grow by 4439.47%. Given that ProPhase Labs has higher upside potential than Icon PLC, analysts believe ProPhase Labs is more attractive than Icon PLC.
Company Buy Ratings Hold Ratings Sell Ratings ICLRIcon PLC11 7 0 PRPHProPhase Labs0 0 0 -
Is ICLR or PRPH More Risky?
Icon PLC has a beta of 1.233, which suggesting that the stock is 23.253% more volatile than S&P 500. In comparison ProPhase Labs has a beta of -0.472, suggesting its less volatile than the S&P 500 by 147.175%.
-
Which is a Better Dividend Stock ICLR or PRPH?
Icon PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ProPhase Labs offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Icon PLC pays -- of its earnings as a dividend. ProPhase Labs pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or PRPH?
Icon PLC quarterly revenues are $2B, which are larger than ProPhase Labs quarterly revenues of $3.1M. Icon PLC's net income of $154.2M is higher than ProPhase Labs's net income of -$6.6M. Notably, Icon PLC's price-to-earnings ratio is 15.09x while ProPhase Labs's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Icon PLC is 1.39x versus 0.92x for ProPhase Labs. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRIcon PLC1.39x 15.09x $2B $154.2M PRPHProPhase Labs0.92x -- $3.1M -$6.6M
-
Which has Higher Returns ICLR or VCYT?
Veracyte has a net margin of 7.7% compared to Icon PLC's net margin of 6.16%. Icon PLC's return on equity of 7.93% beat Veracyte's return on equity of 2.85%.
Company Gross Margin Earnings Per Share Invested Capital ICLRIcon PLC27.91% $1.90 $12.9B VCYTVeracyte69.46% $0.09 $1.2B -
What do Analysts Say About ICLR or VCYT?
Icon PLC has a consensus price target of $183.75, signalling upside risk potential of 32.69%. On the other hand Veracyte has an analysts' consensus of $40.50 which suggests that it could grow by 29.77%. Given that Icon PLC has higher upside potential than Veracyte, analysts believe Icon PLC is more attractive than Veracyte.
Company Buy Ratings Hold Ratings Sell Ratings ICLRIcon PLC11 7 0 VCYTVeracyte7 2 1 -
Is ICLR or VCYT More Risky?
Icon PLC has a beta of 1.233, which suggesting that the stock is 23.253% more volatile than S&P 500. In comparison Veracyte has a beta of 2.145, suggesting its more volatile than the S&P 500 by 114.466%.
-
Which is a Better Dividend Stock ICLR or VCYT?
Icon PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veracyte offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Icon PLC pays -- of its earnings as a dividend. Veracyte pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or VCYT?
Icon PLC quarterly revenues are $2B, which are larger than Veracyte quarterly revenues of $114.5M. Icon PLC's net income of $154.2M is higher than Veracyte's net income of $7M. Notably, Icon PLC's price-to-earnings ratio is 15.09x while Veracyte's PE ratio is 76.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Icon PLC is 1.39x versus 5.33x for Veracyte. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRIcon PLC1.39x 15.09x $2B $154.2M VCYTVeracyte5.33x 76.12x $114.5M $7M
-
Which has Higher Returns ICLR or XWEL?
XWELL has a net margin of 7.7% compared to Icon PLC's net margin of -56.4%. Icon PLC's return on equity of 7.93% beat XWELL's return on equity of -71.82%.
Company Gross Margin Earnings Per Share Invested Capital ICLRIcon PLC27.91% $1.90 $12.9B XWELXWELL24.38% -$0.99 $14.8M -
What do Analysts Say About ICLR or XWEL?
Icon PLC has a consensus price target of $183.75, signalling upside risk potential of 32.69%. On the other hand XWELL has an analysts' consensus of -- which suggests that it could grow by 712.35%. Given that XWELL has higher upside potential than Icon PLC, analysts believe XWELL is more attractive than Icon PLC.
Company Buy Ratings Hold Ratings Sell Ratings ICLRIcon PLC11 7 0 XWELXWELL0 0 0 -
Is ICLR or XWEL More Risky?
Icon PLC has a beta of 1.233, which suggesting that the stock is 23.253% more volatile than S&P 500. In comparison XWELL has a beta of 1.014, suggesting its more volatile than the S&P 500 by 1.396%.
-
Which is a Better Dividend Stock ICLR or XWEL?
Icon PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. XWELL offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Icon PLC pays -- of its earnings as a dividend. XWELL pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ICLR or XWEL?
Icon PLC quarterly revenues are $2B, which are larger than XWELL quarterly revenues of $8.4M. Icon PLC's net income of $154.2M is higher than XWELL's net income of -$4.8M. Notably, Icon PLC's price-to-earnings ratio is 15.09x while XWELL's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Icon PLC is 1.39x versus 0.12x for XWELL. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ICLRIcon PLC1.39x 15.09x $2B $154.2M XWELXWELL0.12x -- $8.4M -$4.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
99
DAVE alert for May 9
Dave [DAVE] is up 9.31% over the past day.
Buy
52
QDEL alert for May 9
QuidelOrtho [QDEL] is down 0.22% over the past day.
Buy
61
TPC alert for May 9
Tutor Perini [TPC] is up 9.61% over the past day.
